Head and Neck Medicine by Alexandros G.Sfakianakis
Δευτέρα 7 Δεκεμβρίου 2020
Downregulation of MCM2 contributes to the reduced growth potential of epithelial progenitor cells in chronic nasal inflammation
pa.ythelady61
shared this article with you from
Inoreader
Downregulation of MCM2 contributes to the reduced growth potential of epithelial progenitor cells in chronic nasal inflammation
Via
Journal of Allergy and Clinical Immunology
Capsule summary: Cell cycle progression candidate MCM2 protein may be a potential target to modulate the epithelial defects (e.g., low proliferation dynamic and impaired barrier function) in chronically airway inflammatory diseases.
View on the web
Inoreader
. Take back control of your news feed. Follow us on
Twitter
and
Facebook
.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
‹
›
Αρχική σελίδα
Προβολή έκδοσης ιστού
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου